News

PolarisQB advances drug safety prediction with quantum-inspired AI, enabling early removal

DURHAM, NC - Polaris Quantum Biotech has been selected as a

DURHAM, NC - Polaris Quantum Biotech (PolarisQB), a leader in

DURHAM, NC - The Defense Advanced Research Projects Agency (DARPA)

DURHAM, NC - Polaris Quantum Biotech (PolarisQB), a leader in

Introduction Computational drug design typically requires a well-defined protein-ligand complex.

Introduction The DARPA IMPAQT ARC Opportunity solicited ideas to

Introduction Fragment-based drug design (FBDD) uses molecular fragments to identify

Introduction Inhibiting Protein-Protein Interactions (PPIs) with small molecules is

On Tuesday, October 1, PolarisQB hosted a webinar titled "Find